Celltrion partners with US pharmacy chain for Yuflyma sales
Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.
CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.
Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.
Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.
Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.
Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.
“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.
Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.
PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.
Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.
-
S.Korea's largest공군 수송기 급파, 한·일 220명 텔아비브 탈출[KH Explains] Amazon's cloud industry plans raise fears of Korean market monopolyDiscussions on need for dialogue on N. Korea denuclearization diminish in US: ambassadorHyundai Rotem to showcase new ground weapons systems at Seoul expo공군 수송기 급파, 한·일 220명 텔아비브 탈출Ruling party chief clings on after election lossJeonse scams cause W510b in losses, with less than 25% recovered: lawmakerCast of ‘Norma’ says opera difficult to sing but easy to enjoyEnhypen announces Nov. 17 comeback with 'Orange Blood'
下一篇:163 S. Koreans arrive home from Israel on military aircraft
- ·김성원 여의도연구원장 "공천장사 지라시, 허위사실 유포로 고소"
- ·Returning minister Yu In
- ·[Herald Review] Lim Hyunsik takes fans for a musical dive into ocean
- ·Enhypen announces Nov. 17 comeback with 'Orange Blood'
- ·Biden says Hamas must be eliminated, US officials warn war could escalate
- ·Unwind with Korea food, lifestyle docs on Netflix
- ·[Coffee Klatch] Take a sip of Turkish coffee in Seoul
- ·Ruling party chief clings on after election loss
- ·163 S. Koreans arrive home from Israel on military aircraft
- ·공군 수송기 급파, 한·일 220명 텔아비브 탈출
- ·BTS' V joined by Jimin in solo fan meeting 'Vicnic'
- ·HD Korea Shipbuilding to build world's first ammonia
- ·S. Korea, US, Japan install trilateral communication hotline amid N. Korea, China challenges
- ·SK to hold CEO meeting in Paris
- ·Gyeongbokgung entrance platform, new signboard unveiled
- ·SK to hold CEO meeting in Paris
- ·[Korea Beyond Korea] In Paris, soaring demand for Korean studies yet to be fully met
- ·LG Innotek wins patents for EV charging technology
- ·[New in Korean] Booker Prize
- ·SK Ecoplant recycles over 6,000 tons of batteries
- ·Gimbap and hanja cramming: Life of Korean Studies students in Paris
- ·Posco Future M achieves 100% recycling of refractory waste
- ·공군 수송기 급파, 한·일 220명 텔아비브 탈출
- ·北, 러 주최 국제포럼서 '국제수송' 논의…무기거래 우회로 찾나
- ·MBK chairman makes donation to promote Korean art at New York's Met
- ·BOK expected to stand pat this week over growth risks: experts
- ·Seoul shares tumble to 5
- ·NK slams Yoon's warning against Pyongyang
- ·LG chief convenes CEO meeting to review growth strategy
- ·Court finds ban on leafleting into NK unconstitutional, ban on praise for NK constitutional
- ·'코로나 봉쇄' 북한, 국경 열었다…3년8개월 만에 외국인 입국
- ·Uzbekistan, Korea boost customs cooperation
- ·[Herald Review] ‘Cobweb,’ a fresh, new wind in the Korean box office
- ·Number of deaths in cycling accidents soars
- ·HMM sale to face hurdles amid slowdown in shipping industry
- ·BOK expected to stand pat this week over growth risks: experts
- ·Korea extends fuel tax cut scheme until year's end
- ·[Korea Beyond Korea] In Paris, soaring demand for Korean studies yet to be fully met
- ·Andong, serene destination for immersing in traditions
- ·Seoul shares open lower ahead of earnings season
- ·HD Korea Shipbuilding to build world's first ammonia
- ·[Korea Beyond Korea] In Paris, soaring demand for Korean studies yet to be fully met
- ·Seoul defense exhibition aims to boost arms exports